Clinical Trials Directory

Trials / Completed

CompletedNCT01913379

Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole

A Phase I Randomized, Open-label, 3-arm Parallel-design Study to Determine the Effect of Multiple-dose Gemfibrozil or Itraconazole on the Pharmacokinetics, Safety and Tolerability of Single-dose MDV3100 (ASP9785) in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Astellas Pharma Europe B.V. · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

A study to assess possible drug-drug interactions between MDV3100 and gemfibrozil and MDV3100 and Itraconazole.

Conditions

Interventions

TypeNameDescription
DRUGMDV3100Oral
DRUGGemfibrozilOral
DRUGItraconazoleOral

Timeline

Start date
2011-08-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2013-08-01
Last updated
2013-08-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01913379. Inclusion in this directory is not an endorsement.